The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.
“Keys Bags Names Words” is a hopeful Alzheimer’s movie. The film portrays stories of young scientists and artists from around the world in, their effort to help those who are affected.
Tau PET is an imaging test used to detect the presence of tau protein in the brain. Researchers say it’s the best way to predict the rate of cognitive decline due to Alzheimer’s.
Researchers at UCI found that breathing in aromas while sleeping sparks a 226% cognitive increase.
Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day.
What’s it like having early-onset dementia? Find out today from Jason, who shares his answers with viewers who have asked about his experiences and those of his wife Leslie.
The future of millions at risk for dementia could change with the use of hearing aids. Learn more.
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.
Can miniature towns make dementia care more humane? Designers of The Hogeweyk dementia village in Netherlands believe so.
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.
We are all broken. That’s how the light gets in. Ernest Hemingway
The diagnostic and treatment network behind Leqembi may be its biggest competitive edge.
Dementia creates difficult moments when responding to delusions. Watch how Teepa Snow, Dementia Care Specialist, provides strategies to manage these situations with respect and dignity.
In dementia, art is often expressed at a much higher level than other activities. People engaged in artistic activities when they were healthy may hold on to these abilities in a way that seems to defy Alzheimer’s. See the remarkable case of one Canadian sculptor.
One woman held the genetic key to unlock the mystery of how she was the only one free of early-onset Alzheimer’s, out of 1,200 members of a South American family,
Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
No spam, only news and updates.
